DK1150662T3 - Laminater indeholdende aktivt stof til transdermale systemer - Google Patents
Laminater indeholdende aktivt stof til transdermale systemerInfo
- Publication number
- DK1150662T3 DK1150662T3 DK00907516T DK00907516T DK1150662T3 DK 1150662 T3 DK1150662 T3 DK 1150662T3 DK 00907516 T DK00907516 T DK 00907516T DK 00907516 T DK00907516 T DK 00907516T DK 1150662 T3 DK1150662 T3 DK 1150662T3
- Authority
- DK
- Denmark
- Prior art keywords
- active substance
- containing active
- transdermal systems
- sex hormone
- laminates containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Laminated Bodies (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19906152A DE19906152B4 (de) | 1999-02-10 | 1999-02-10 | Wirkstoffhaltige Laminate für Transdermalsysteme |
PCT/EP2000/000983 WO2000047191A1 (de) | 1999-02-10 | 2000-02-08 | Wirkstoffhaltige laminate für transdermalsysteme |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1150662T3 true DK1150662T3 (da) | 2004-01-26 |
Family
ID=7897479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00907516T DK1150662T3 (da) | 1999-02-10 | 2000-02-08 | Laminater indeholdende aktivt stof til transdermale systemer |
Country Status (11)
Country | Link |
---|---|
US (1) | US6902741B1 (da) |
EP (1) | EP1150662B1 (da) |
JP (1) | JP4132679B2 (da) |
AT (1) | ATE249818T1 (da) |
AU (1) | AU2908000A (da) |
CA (1) | CA2372710C (da) |
DE (2) | DE19906152B4 (da) |
DK (1) | DK1150662T3 (da) |
ES (1) | ES2207488T3 (da) |
PT (1) | PT1150662E (da) |
WO (1) | WO2000047191A1 (da) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0116793B8 (pt) * | 2000-12-14 | 2021-05-25 | Johnson & Johnson | produtos de hormônio de esteróide e métodos para prepará-los |
EA009024B1 (ru) | 2002-06-25 | 2007-10-26 | АКРУКС ДиДиЭс ПиТиУай ЭлТиДи | Фармацевтическая композиция для чрескожной доставки активного агента (варианты) |
AU2004212675B2 (en) | 2003-02-21 | 2006-06-01 | Bayer Intellectual Property Gmbh | UV stable transdermal therapeutic plaster |
JP4422430B2 (ja) * | 2003-05-14 | 2010-02-24 | 帝國製薬株式会社 | エストロゲン及び/又はプロゲストゲン含有外用貼付剤 |
DE10348046A1 (de) * | 2003-10-16 | 2005-05-19 | Beiersdorf Ag | Verfahren zur Herstellung von Matrizes für transdermale oder topicale Wirkstoffsysteme |
UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
JP4965263B2 (ja) * | 2003-12-12 | 2012-07-04 | バイエル ファーマ アクチエンゲゼルシャフト | 浸透増強剤を必要としないホルモンの経皮送達 |
DE102004016779A1 (de) * | 2004-04-01 | 2006-01-19 | Schering Ag | Drospirenonhaltige Zubereitungen zur transdermalen Anwendung |
US20080138390A1 (en) * | 2004-04-07 | 2008-06-12 | Tsung-Min Hsu | Transdermal Delivery System For Use With Basic Permeation Enhancers |
US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
CN102091079B (zh) * | 2005-06-03 | 2014-03-12 | 艾克若克斯Dds有限公司 | 用于透皮给药的方法和组合物 |
DE102006026578B4 (de) | 2006-06-08 | 2009-01-08 | Lts Lohmann Therapie-Systeme Ag | Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung |
KR101301116B1 (ko) | 2007-01-11 | 2013-09-03 | 애크럭스 디디에스 피티와이 리미티드 | 분산 기구 |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
EP2111857A1 (de) * | 2008-04-25 | 2009-10-28 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon |
AU2009262871B2 (en) * | 2008-05-30 | 2016-04-14 | Mylan Inc. | Stabilized transdermal drug delivery system |
KR20110082142A (ko) | 2008-10-06 | 2011-07-18 | 밀란 테크놀로지즈 인코포레이티드 | 비정질 로티고틴 경피 시스템 |
DE102010040299A1 (de) | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
HUE031326T2 (hu) * | 2010-09-06 | 2017-07-28 | Bayer Ip Gmbh | Alacsony dózisú transzdermális tapaszok magas hatóanyagleadással |
USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
JP6757351B2 (ja) | 2017-04-28 | 2020-09-16 | 日東電工株式会社 | 経皮吸収型製剤 |
WO2022212529A1 (en) * | 2021-03-30 | 2022-10-06 | Viatris Inc. | Transdermal systems having low dose estrogen and methods of making and use |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2920500A1 (de) * | 1979-05-21 | 1980-11-27 | Boehringer Sohn Ingelheim | Pharmazeutische zubereitung in form eines polyacrylatfilmes |
FR2542998B1 (fr) * | 1983-03-24 | 1986-01-31 | Rhone Poulenc Sante | Nouvelle forme transdermale du dinitrate d'isosorbide |
JPS6193112A (ja) * | 1984-06-15 | 1986-05-12 | Sekisui Chem Co Ltd | 貼付剤 |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
US5028435A (en) * | 1989-05-22 | 1991-07-02 | Advanced Polymer Systems, Inc. | System and method for transdermal drug delivery |
US5232703A (en) * | 1989-07-21 | 1993-08-03 | Izhak Blank | Estradiol compositions and methods for topical application |
DE3933460A1 (de) * | 1989-10-06 | 1991-04-18 | Lohmann Therapie Syst Lts | Oestrogenhaltiges wirkstoffpflaster |
IT1243745B (it) * | 1990-10-17 | 1994-06-21 | Vectorpharma Int | Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione. |
IT1250421B (it) | 1991-05-30 | 1995-04-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive. |
DE4332284C2 (de) | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4332283A1 (de) | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4334553C2 (de) | 1993-10-11 | 1998-05-20 | Synopharm Gmbh Pharmazeutische | Flüssiges pharmazeutisches System zur perkutanen Applikation |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
FR2717688B1 (fr) * | 1994-03-28 | 1996-07-05 | Lhd Lab Hygiene Dietetique | Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA. |
DE4429397C2 (de) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
DE4429398C2 (de) | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption |
IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
JP3628809B2 (ja) * | 1996-06-10 | 2005-03-16 | アルケア株式会社 | 薬剤徐放性医療用配合物及びその製造方法 |
DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
DE19652196A1 (de) | 1996-12-16 | 1998-06-18 | Jenapharm Gmbh | Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen |
DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
JPH10306023A (ja) * | 1997-05-06 | 1998-11-17 | Sekisui Chem Co Ltd | 経皮吸収製剤及びその製造方法 |
DE19809845A1 (de) | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
US6312715B1 (en) * | 1998-05-01 | 2001-11-06 | 3M Innovative Properties Company | Adhesive microsphere drug delivery composition |
-
1999
- 1999-02-10 DE DE19906152A patent/DE19906152B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 PT PT00907516T patent/PT1150662E/pt unknown
- 2000-02-08 US US09/913,112 patent/US6902741B1/en not_active Expired - Lifetime
- 2000-02-08 JP JP2000598144A patent/JP4132679B2/ja not_active Expired - Fee Related
- 2000-02-08 CA CA002372710A patent/CA2372710C/en not_active Expired - Fee Related
- 2000-02-08 DK DK00907516T patent/DK1150662T3/da active
- 2000-02-08 DE DE50003721T patent/DE50003721D1/de not_active Expired - Lifetime
- 2000-02-08 WO PCT/EP2000/000983 patent/WO2000047191A1/de active IP Right Grant
- 2000-02-08 ES ES00907516T patent/ES2207488T3/es not_active Expired - Lifetime
- 2000-02-08 AU AU29080/00A patent/AU2908000A/en not_active Abandoned
- 2000-02-08 AT AT00907516T patent/ATE249818T1/de active
- 2000-02-08 EP EP00907516A patent/EP1150662B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2207488T3 (es) | 2004-06-01 |
JP4132679B2 (ja) | 2008-08-13 |
DE19906152A1 (de) | 2000-08-17 |
DE50003721D1 (de) | 2003-10-23 |
CA2372710C (en) | 2006-04-11 |
DE19906152B4 (de) | 2005-02-10 |
EP1150662B1 (de) | 2003-09-17 |
ATE249818T1 (de) | 2003-10-15 |
EP1150662A1 (de) | 2001-11-07 |
JP2002536403A (ja) | 2002-10-29 |
CA2372710A1 (en) | 2000-08-17 |
PT1150662E (pt) | 2004-02-27 |
US6902741B1 (en) | 2005-06-07 |
AU2908000A (en) | 2000-08-29 |
WO2000047191A1 (de) | 2000-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1150662T3 (da) | Laminater indeholdende aktivt stof til transdermale systemer | |
CA1272954A (en) | Ph-mediated drug delivery system | |
KR100628796B1 (ko) | 에스트라디올과 다른 스테로이드를 함께 투여하기 위한 경피약물 송달기제 | |
AU679794B2 (en) | Monoglyceride/lactate ester permeation enhancer for oxybutynin | |
HRP20050828B1 (hr) | Uv-stabilni transdermalni flaster | |
SE9803871D0 (sv) | Therapeutic method and formulation | |
FI960556A0 (fi) | Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä | |
IL160515A0 (en) | Transdermal therapeutic system (tts) with fentanyl as active ingredient | |
DK1691851T3 (da) | Sårplaster og fremgangsmåder | |
BRPI0507683A (pt) | dose unitária com liberação de formulação farmacêutica com liberação controlada, processo para sua preparação, bem como uso de um copolìmero de poli(acrilato de etila, metacrilato de metila) neutro | |
DK1021204T3 (da) | Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler | |
PT80865B (pt) | Dispositivo de libertacao de um principio activo | |
NO974194L (no) | Forbedringer i, eller vedrörende, organiske sammensetninger | |
DK1355636T3 (da) | Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf | |
FR2801507B1 (fr) | Dispositif transdermique auto-adhesif comprenant un reservoir et une matrice contenant le meme principe actif, son procede de preparation et ses utilisations | |
BR9908910A (pt) | Sistema terapêutico transdérmico (tts) para a administração transcutânea de oxibutinina e método para sua preparação | |
DK1152751T3 (da) | Transdermalt, terapeutisk desoxypeganinsysstem | |
NL192780B (nl) | Werkwijze om een in water zwelbaar, in water onoplosbaar, sterk hydrofiel polymeer te voorzien van een farmaceutisch actieve stof. | |
DK1284718T3 (da) | Okklusivt transdermalt terapeutisk system med et ikke-okklusivt baglag | |
WO2005046600A3 (en) | Transdermal tulobuterol delivery | |
ATE340567T1 (de) | Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol | |
CA3175771A1 (en) | Transdermal and/or topical delivery system comprising hydroxychloroquine and/or chloroquine | |
ATE20311T1 (de) | Polymerische diffusionsmatritze propranolol enthaltend. | |
CA2370023A1 (en) | Transdermal therapeutic system with a highly effective neuroleptic agent | |
BR0001923A (pt) | Estação de comutação de rádio e método para distribuir chamadas |